Marie Irondelle

Team1, Equipe Labellisée Ligue 2020 And Equipe Labellisée ARC 2019
Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Primary Cilium Forces Neuroendocrine Shift in Prostate Cancer through YAP1 Repression and Reduced Mitochondrial Activity.

Primary Cilium Forces Neuroendocrine Shift in Prostate Cancer through YAP1 Repression and Reduced Mitochondrial Activity.

Journal: Theranostics

Published: October 13, 2025

Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway.

Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway.

Journal: Oncogenesis

Published: August 25, 2025

SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.

SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.

Journal: Cell death & disease

Published: April 28, 2025

USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization.

USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization.

Journal: Cell reports

Published: January 29, 2025

Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness.

Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness.

Journal: Nature communications

Published: November 29, 2024

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Journal: EMBO molecular medicine

Published: August 20, 2024

YAP1 modulation of primary cilia-mediated ciliogenesis in 2D and 3D prostate cancer models.

YAP1 modulation of primary cilia-mediated ciliogenesis in 2D and 3D prostate cancer models.

Journal: FEBS letters

Published: May 07, 2024

HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.

HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.

Journal: Cell death discovery

Published: March 08, 2024

The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes.

The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes.

Journal: Cellular & molecular biology letters

Published: March 08, 2024

HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.

HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.

Journal: bioRxiv : the preprint server for biology

Published: October 31, 2023

Bax Inhibitor-1 preserves pancreatic β-cell proteostasis by limiting proinsulin misfolding and programmed cell death.

Bax Inhibitor-1 preserves pancreatic β-cell proteostasis by limiting proinsulin misfolding and programmed cell death.

Journal: Cell death & disease

Published: July 18, 2023

The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment.

The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment.

Journal: Cell death & disease

Published: June 13, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026